Exploring the Role of Prostaglandin D2 and the DP1 Receptor on Nicotinic Acid Induced Flushing.
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2010
At a glance
- Drugs Aspirin; Niacin
- Indications Dyslipidaemias; Myocardial infarction; Pain; Rheumatic disorders; Stroke; Thrombosis
- Focus Pharmacodynamics
- 11 Mar 2010 Actual number of patients added to 30 as reported by ClinicalTrials.gov.
- 11 Mar 2010 Actual end date added to 1 Feb 2010 as reported by ClinicalTrials.gov.
- 11 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.